Novartis Spins Off 3 Drugs To New UK Biopharma Company
Novartis AG has sold three midstage clinical drugs to a newly formed U.K.-based pharmaceutical company in exchange for equity, the pharmaceutical giant announced on Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article